CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
Carbidopa-Levodopa +6 moredrug
Likely dose
Carbidopa-Levodopa 25mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00715520
NCT00715520N/ACompleted

Neurobiological Principles Applied to the Rehabilitation of Stroke Patients

Emory University·interventional·Posted Jul 15, 2008·Updated Oct 16, 2017

In Brief

A clinical study evaluating Transcranial Magnetic Stimulation (TMS), Carbidopa-Levodopa, and 5 other interventions for Stroke. Completed, enrolled 33 participants across 1 site.

Detailed Summary

The purpose of this study is to use (Transcranial Magnetic Stimulation) TMS or drugs to improve learning of movement skills and the adaptation processes in patients after stroke. Once investigators have determined the improving effect of TMS and the drugs on learning of movement skills, the study team may be able to provide information that improves rehabilitative treatment and helps to improve recovery after stroke.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 15, 2008
Enrollment StartApr 1, 2007
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9.4 yearsPosted 18.0 years ago

Interventions

Transcranial Magnetic Stimulation (TMS)other

Each TMS training session will begin with a baseline measurement lasting about 30 minutes in which brief magnetic pulses will be generated by the single-pulse and paired pulse TMS stimulator and the responses are recorded with surface EMG electrodes. Participants will be instructed to move their wrist for up to ½ hour. After these measures, rTMS will be applied to the scalp during training. Stimulation will occur at a low rate of different frequencies and different times with respect to the training movement depending on the experimental condition. In the last phase of the session post-training measurements will be done using single TMS pulses. TMS pulses and intensity with be given in random order.

Carbidopa-Levodopadrug

Participants will receive one oral dose of carbidopa-levodopa 25mg one hour prior to measuring wrist extension movements. The order in which Carbidopa-Levodopa is given will be randomized per participant.

Methylphenidatedrug

Participants will receive one oral dose of methylphenidate 40mg 2 hours prior to measuring wrist extension movements. The order in which Methylphenidate is given will be randomized per participant.

Amphetamine Sulfatedrug

Participants will receive one oral dose of amphetamine sulfate 10mg 2 hours prior to measuring wrist extension movements. The order in which Amphetamine Sulfate is given will be randomized per participant.

Placebodrug

Participants will receive one oral tablet of placebo 2 hours prior to measuring wrist extension movements. The order in which Placebo is given will be randomized per participant.

Sham Transcranial Magnetic Stimulation (TMS)other

Sham TMS pulses will be randomly administered during TMS sessions.

Transcranial Magnetic Stimulation (TMS) Trainingother

TMS surface electromyographic activity will be recorded with surface electrodes mounted on the skin overlaying a forearm muscle. Single pulses of TMS at increasing intensity will be delivered to measure motor cortex excitability. Peak acceleration and TMS evoked responses in the muscle will be measured prior to the training, after completion of the training and again one hour after completion of the training.